CNS/Brain Cancer
Feature
Cancer patients report delays in treatment because of COVID-19
Half of survey respondents in active treatment reported changes, delays, or disruptions to care.
From the Journals
Cancer care ‘transformed in space of a month’ because of pandemic
Changes brought about by COVID-19 may endure after the pandemic is over.
From the Journals
Oncologists need to advocate for scarce COVID-19 resources: ASCO
The oncologist treating a patient should not make decisions about resource allocation for that patient, ASCO says.
Feature
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
From the Journals
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
From the Journals
Managing pediatric heme/onc departments during the pandemic
An international group has devised a plan for preventing the spread of infection, treating COVID-19, and adjusting cancer treatments.
Feature
Conducting cancer trials amid the COVID-19 pandemic
From the Journals
‘Brutal’ plan to restrict palliative radiation during pandemic
New guidelines recommend giving palliative radiotherapy only in oncologic emergencies during the COVID-19 pandemic.
Feature
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
From the Journals
No staff COVID-19 diagnoses after plan at Chinese cancer center